Clinical Trials Directory

Trials / Completed

CompletedNCT04805684

Different Lung Ultrasound Imaging Protocols in COVID-19 Pneumonia

Comparison of Two Different Lung Ultrasound Imaging Protocols in COVID -19 Pneumonia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
59 (actual)
Sponsor
Bursa Yuksek Ihtisas Training and Research Hospital · Other Government
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Lung ultrasonography (LUS) is also used in COVID 19 pneumonia for diagnostic and follow-up purposes.It has been demonstrated in different studies that it can be used for pathologies in pleural and lung tissue. LUS was applied by different researchers by dividing the lungs into 12 and 14 regions and the results were shared.

Detailed description

In our study, we aimed to determine the correlation between lung findings of COVID 19 pneumonia and thoracic tomography with the results of LUS applied to different numbers (12 versus 14) of areas.

Conditions

Interventions

TypeNameDescription
DEVICELUS Twelve areaApplication of 12 areas (2 posterior, 2 lateral, and 2 anterior)lung ultrasonography protocol using the convex ultrasound probe (2-6 MHz)
DEVICELUS Fourteen areaApplication of 14 areas (3 posterior, 2 lateral, and 2 anterior) lung ultrasonography protocol using the convex ultrasound probe (2-6 MHz)

Timeline

Start date
2021-01-01
Primary completion
2021-03-05
Completion
2021-03-05
First posted
2021-03-18
Last updated
2021-03-18

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04805684. Inclusion in this directory is not an endorsement.